Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cdz173
1. 1354690-24-6
2. Cdz173
3. Leniolisib [inn]
4. Leniolisib Free Base
5. Cdz173 Free Base
6. Cdz-173 Free Base
7. Cdz173-nx
8. Cdz-173-nx
9. (s)-1-(3-((6-(6-methoxy-5-(trifluoromethyl)pyridin-3-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)amino)pyrrolidin-1-yl)propan-1-one
10. L22772z9cp
11. 1-[(3s)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5h-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one
12. Cdz-173
13. 1-propanone, 1-((3s)-3-((5,6,7,8-tetrahydro-6-(6-methoxy-5-(trifluoromethyl)-3-pyridinyl)pyrido(4,3-d)pyrimidin-4-yl)amino)-1-pyrrolidinyl)-
14. Leniolisib (cdz173)
15. Leniolisib; Cdz173
16. Leniolisib (usan/inn)
17. Leniolisib [usan]
18. Leniolisib [who-dd]
19. Schembl323054
20. Unii-l22772z9cp
21. Gtpl9424
22. Chembl3643413
23. Bdbm118299
24. Glxc-25777
25. Ex-a2854
26. Mfcd30470232
27. S8752
28. Zb1510
29. Cs-7524
30. Dc22326
31. Example 67 [wo2012004299]
32. 1-{(s)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-y
33. 1-{(s)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-ylamino]-pyrrolidin-1-yl}-propan-1-one
34. Ac-35599
35. As-56217
36. Hy-17635
37. A16796
38. D11158
39. Us8653092, 67
40. Q27282602
41. 1-((3s)-3-((6-(6-methoxy-5-(trifluoromethyl)pyrimidin-3-yl)-5,6,7,8-tetrahydropyrido(4,3-d)pyrimidin-4-yl)amino)pyrrolidin-1-yl)propan-1-one
42. 9nq
Molecular Weight | 450.5 g/mol |
---|---|
Molecular Formula | C21H25F3N6O2 |
XLogP3 | 2.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 5 |
Exact Mass | 450.19910855 g/mol |
Monoisotopic Mass | 450.19910855 g/mol |
Topological Polar Surface Area | 83.5 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 654 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
97
PharmaCompass offers a list of Leniolisib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Leniolisib manufacturer or Leniolisib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Leniolisib manufacturer or Leniolisib supplier.
PharmaCompass also assists you with knowing the Leniolisib API Price utilized in the formulation of products. Leniolisib API Price is not always fixed or binding as the Leniolisib Price is obtained through a variety of data sources. The Leniolisib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Leniolisib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Leniolisib, including repackagers and relabelers. The FDA regulates Leniolisib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Leniolisib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Leniolisib supplier is an individual or a company that provides Leniolisib active pharmaceutical ingredient (API) or Leniolisib finished formulations upon request. The Leniolisib suppliers may include Leniolisib API manufacturers, exporters, distributors and traders.
Leniolisib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Leniolisib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Leniolisib GMP manufacturer or Leniolisib GMP API supplier for your needs.
A Leniolisib CoA (Certificate of Analysis) is a formal document that attests to Leniolisib's compliance with Leniolisib specifications and serves as a tool for batch-level quality control.
Leniolisib CoA mostly includes findings from lab analyses of a specific batch. For each Leniolisib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Leniolisib may be tested according to a variety of international standards, such as European Pharmacopoeia (Leniolisib EP), Leniolisib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Leniolisib USP).